Health
Race Against Time for Ebola Drug in Congo: 'Children Are Left Behind'
In the Democratic Republic of Congo, doctors are treating patients with the Bundibugyo Ebola variant, which lacks a specific vaccine or drug and has a 48% fatality rate. An international study is testing antiviral drugs remdesivir and MBP134 to improve survival rates, as families suffer devastating losses and children are often left orphaned while researchers seek a breakthrough treatment.
Ozetta summarises; the reporting is the newsroom's